INSIDER · CIK 1909362
Aslan Fred
Chief Executive Officer, Director at Artiva Biotherapeutics, Inc. (ARTV)
↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.5MSold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:02 | Oct 6, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $7.20 | −23,463 | 1,519,606 | -2% | −$169K | ||
| Oct 6, 202616:01 | Oct 5, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | S · Sell | $6.84 | −61,696 | 1,543,069 | -4% | −$422K | ||
| Sep 15, 202616:44 | Sep 15, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | A · Grant | — | +110,000 | 1,604,765 | +7% | — | ||
| Sep 14, 202620:07 | Sep 10, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | A · Grant | — | +45,000 | 1,494,765 | +3% | — | ||
| Sep 9, 202616:02 | Sep 8, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $10.92 | −23,429 | 1,449,765 | -2% | −$256K | ||
| Sep 4, 202616:02 | Sep 3, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer, Director | S · Sell | $11.16 | −61,888 | 1,473,194 | -4% | −$690K |